Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Molecular Cancer Therapeutics|May 5, 2017
Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses <i>NF2</i> Loss-Driven TumorigenesisJonathan Cooper, Qingwen Xu, Lu Zhou, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 11, 2024
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlatesCarolyn A Young, Amina Chaouch, Christopher J Mcdermott, et al.Science Signaling|September 1, 2011
Merlin/NF2 functions upstream of the nuclear E3 ubiquitin ligase CRL4DCAF1 to suppress oncogenic gene expressionJonathan Cooper, Wei Li, Liru You, et al.Cell|February 25, 2010
Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleusWei Li, Liru You, Jonathan Cooper, et al.EMBO Reports|January 15, 2024
Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growthLaura R Diaz, Jon Gil-Ranedo, Karolina J Jaworek, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 23, 2019
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron diseaseCarolyn Anne Young, John Ealing, Christopher McDermott, et al.Oncogene|August 23, 2024
Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumoursForam Dave, Kevin Herrera, Alex Lockley, et al.Neuropathology and Applied Neurobiology|April 12, 2024
Adult brain tumour research in 2024: Status, challenges and recommendationsKarin Purshouse, Helen J Bulbeck, Alasdair G Rooney, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2020
Measuring quality of life in ALS/MND: validation of the WHOQOL-BREFCarolyn A Young, Roger Mills, Ammar Al-Chalabi, et al.Journal of the Neurological Sciences|March 18, 2022
The four self-efficacy trajectories among people with multiple sclerosis: Clinical associations and implicationsCarolyn A Young, Roger Mills, Dawn Langdon, et al.Pageof 8